News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
43,024 Results
Type
Article (2753)
Company Profile (46)
Press Release (40224)
Multimedia
Podcasts (9)
Webinars (3)
Section
Business (15119)
Career Advice (86)
Deals (2284)
Drug Delivery (9)
Drug Development (4385)
Employer Resources (13)
FDA (470)
Job Trends (879)
News (21627)
Policy (1157)
Tag
Academia (168)
Allergies (7)
Alliances (3748)
ALS (8)
Alzheimer's disease (66)
Antibody-drug conjugate (ADC) (29)
Approvals (477)
Artificial intelligence (33)
Autoimmune disease (9)
Automation (3)
Bankruptcy (12)
Best Places to Work (568)
BIOSECURE Act (2)
Biosimilars (21)
Biotechnology (29)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (46)
Cancer (360)
Cardiovascular disease (16)
Career advice (74)
Career pathing (1)
CAR-T (32)
CDC (1)
Cell therapy (86)
Cervical cancer (3)
Clinical research (3644)
Collaboration (227)
Company closure (2)
Compensation (106)
COVID-19 (201)
CRISPR (12)
C-suite (117)
Cystic fibrosis (7)
Data (448)
Denatured (6)
Depression (11)
Diabetes (21)
Diagnostics (536)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (3)
Drug discovery (38)
Drug pricing (10)
Duchenne muscular dystrophy (40)
Earnings (4938)
Editorial (5)
Employer branding (2)
Employer resources (12)
Events (6848)
Executive appointments (136)
FDA (637)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (178)
Gene editing (33)
Generative AI (1)
Gene therapy (57)
GLP-1 (68)
Government (187)
Guidances (33)
Healthcare (876)
HIV (6)
Huntington's disease (5)
IgA nephropathy (13)
Immunology and inflammation (37)
Immuno-oncology (17)
Indications (5)
Infectious disease (218)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (29)
Interviews (7)
IPO (1079)
IRA (7)
Job creations (303)
Job search strategy (69)
JPM (5)
Kidney cancer (6)
Labor market (11)
Layoffs (57)
Leadership (3)
Legal (227)
Liver cancer (7)
Longevity (1)
Lung cancer (30)
Lymphoma (13)
Machine learning (3)
Management (4)
Manufacturing (67)
MASH (15)
Medical device (391)
Medtech (392)
Mergers & acquisitions (1323)
Metabolic disorders (78)
Multiple sclerosis (23)
Neurodegenerative disease (30)
Neuropsychiatric disorders (10)
Neuroscience (180)
NextGen: Class of 2026 (386)
Non-profit (206)
Now hiring (11)
Obesity (35)
Opinion (23)
Ovarian cancer (18)
Pain (25)
Pancreatic cancer (22)
Parkinson's disease (12)
Partnered (4)
Patents (57)
Patient recruitment (29)
Peanut (1)
People (6118)
Pharmaceutical (5)
Phase 1 (1561)
Phase 2 (1789)
Phase 3 (972)
Pipeline (434)
Policy (16)
Postmarket research (34)
Preclinical (668)
Press Release (2)
Prostate cancer (10)
Psychedelics (3)
Radiopharmaceuticals (16)
Rare diseases (72)
Real estate (457)
Recruiting (6)
Regulatory (997)
Reports (7)
Research institute (167)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (3)
Schizophrenia (16)
Series A (47)
Series B (21)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (515)
Stomach cancer (3)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (62)
Venture capital (16)
Weight loss (22)
Women's health (10)
Worklife (2)
Date
Last 7 days (46)
Last 30 days (173)
Last 365 days (2626)
2026 (236)
2025 (2657)
2024 (2828)
2023 (3110)
2022 (4085)
2021 (4388)
2020 (3731)
2019 (2409)
2018 (1826)
2017 (1949)
2016 (1747)
2015 (1956)
2014 (1426)
2013 (1235)
2012 (1431)
2011 (1370)
2010 (1204)
Location
Africa (51)
Alabama (3)
Arizona (19)
Asia (2188)
Australia (341)
California (1664)
Canada (266)
China (88)
Colorado (58)
Connecticut (16)
Delaware (7)
Europe (4582)
Florida (72)
Georgia (17)
Hawaii (2)
Idaho (6)
Illinois (27)
India (4)
Indiana (68)
Japan (18)
Kansas (15)
Kentucky (1)
Maryland (53)
Massachusetts (597)
Michigan (14)
Minnesota (23)
Mississippi (1)
Missouri (7)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (169)
New York (91)
North Carolina (135)
Northern California (822)
Ohio (46)
Oklahoma (2)
Oregon (6)
Pennsylvania (122)
Puerto Rico (1)
Rhode Island (2)
South America (54)
South Carolina (1)
Southern California (670)
Tennessee (5)
Texas (165)
United States (3421)
Utah (7)
Virginia (13)
Washington D.C. (3)
Washington State (97)
West Virginia (1)
Wisconsin (14)
43,024 Results for "pillar biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pillar Biosciences Announces Final CMS Pricing Determination for oncoReveal® CDx
December 2, 2025
·
1 min read
Press Releases
QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars
February 5, 2026
·
8 min read
Press Releases
QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth
January 12, 2026
·
10 min read
Press Releases
GenomOncology and Pillar Biosciences Announce Co-Marketing Partnership to Advance Rapid Precision Oncology Solutions
February 14, 2025
·
3 min read
FDA
Pillar Biosciences oncoReveal™ CDx pan-cancer solid tumor IVD now FDA approved for general tumor profiling on the Illumina MiSeq™ Dx System
Pillar Biosciences, Inc., the leader in Decision Medicine™ today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Premarket Approval (PMA) supplement application for its oncoReveal™ CDx pan-cancer solid tumor in vitro diagnostic (IVD).
April 23, 2024
·
3 min read
Genetown
Pillar Biosciences to Present at NYBIO | NYSE Life Science Company Showcase on December 14th
Pillar Biosciences is pleased to announce that Randy Pritchard , Chief Executive Officer, and Vincent Ricci , Chief Financial Officer, will be presenting at the NYBIO | NYSE Life Science Company Showcase on December 14th.
December 7, 2023
·
2 min read
Press Releases
OSE Immunotherapeutics strengthens Growth Strategy: Accelerates key pillars of Inflammation and Immuno-Oncology
June 4, 2025
·
9 min read
Business
Pillar Biosciences and KeyGene Enter into Licensing Agreement
Pillar Biosciences, Inc. today announced a non-exclusive licensing agreement with Keygene N.V. related to their patent family entitled Combinatorial sequence barcodes for high throughput screening for use in Pillar Biosciences products, kits or services used for research or clinical testing.
April 13, 2023
·
3 min read
Business
Illumina and Pillar Biosciences partner to improve access to personalized cancer treatment options
Illumina Inc. and Pillar Biosciences Inc., the pioneers of Decision Medicine™, today announced a strategic partnership to make Pillar’s suite of oncology assays commercially available globally as part of the Illumina portfolio of oncology products.
July 25, 2023
·
4 min read
Genetown
Pillar Biosciences to Present New Scientific Data at Association for Molecular Pathology Annual Meeting
Pillar Biosciences, Inc., the leader in Decision Medicine™, today announced the company and scientific collaborators will collectively present eleven studies and two corporate workshops at the 2023 Association for Molecular Pathology (AMP) Annual Meeting from November 14 -18, 2023 in Salt Lake City, UT (Booth #619).
November 8, 2023
·
3 min read
1 of 4,303
Next
